Comparative Study of the Efficacies of Neurosurgical Treatment (electrostimulation of the subthalamic nucleus) and Drug Treatment at the Advanced Stage of Parkinson’s Disease

[1]  Elena Moro,et al.  Deep brain stimulation for Parkinsons disease , 2014 .

[2]  Anthony H V Schapira,et al.  Timing of Deep Brain Stimulation in Parkinson Disease: A Need for Reappraisal? , 2013, Annals of neurology.

[3]  C. Tanner.  A second honeymoon for Parkinson's disease? , 2013, The New England journal of medicine.

[4]  G. Deuschl,et al.  Neurostimulation for Parkinson's disease with early motor complications. , 2013, The New England journal of medicine.

[5]  Charles D. Spielberger,et al.  State-Trait Anxiety Inventory for Adults , 2012 .

[6]  A. Lang,et al.  Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation. , 2011, Archives of neurology.

[7]  M. Behbehani,et al.  Stimulation of the rat subthalamic nucleus is neuroprotective following significant nigral dopamine neuron loss , 2010, Neurobiology of Disease.

[8]  Keith Wheatley,et al.  Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial , 2010, The Lancet Neurology.

[9]  C. Spielberger.  State‐Trait Anxiety Inventory , 2010 .

[10]  K. Dujardin,et al.  A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. , 2008, Brain : a journal of neurology.

[11]  G. Deuschl,et al.  A randomized trial of deep-brain stimulation for Parkinson's disease. , 2006, The New England journal of medicine.

[12]  Rajesh Pahwa,et al.  Deep brain stimulation: Preoperative issues , 2006, Movement disorders : official journal of the Movement Disorder Society.

[13]  P. Warnke.  STN stimulation and neuroprotection in Parkinson’s disease—when beautiful theories meet ugly facts , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[14]  R. P. Maguire,et al.  Disease progression continues in patients with advanced Parkinson’s disease and effective subthalamic nucleus stimulation , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[15]  J. Volkmann.  DEEP BRAIN STIMULATION II Deep Brain Stimulation for the Treatment of Parkinson’s Disease , 2004 .

[16]  R. Hills,et al.  Surgery for Parkinson’s disease: lack of reliable clinical trial evidence , 2003, Journal of neurology, neurosurgery, and psychiatry.

[17]  J. Molinuevo,et al.  Levodopa withdrawal after bilateral subthalamic nucleus stimulation in advanced Parkinson disease. , 2000, Archives of neurology.

[18]  R. Fitzpatrick,et al.  The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. , 1997, Age and ageing.

[19]  M. Hamilton,et al.  Development of a rating scale for primary depressive illness. , 1967, The British journal of social and clinical psychology.

[20]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[21]  M. Gelabert-González,et al.  [Deep brain stimulation in Parkinson's disease]. , 2013, Revista de neurologia.

[22]  G. Deuschl,et al.  Stimulation of the subthalamic nucleus at an earlier disease stage of Parkinson's disease: concept and standards of the EARLYSTIM-study. , 2013, Parkinsonism & related disorders.

[23]  Victor R. Preedy,et al.  Spielberger State-Trait Anxiety Inventory , 2010 .

[24]  P. A. House,et al.  Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients With Advanced Parkinson Disease: A Randomized Controlled Trial , 2009 .

[25]  Z. Schwab,et al.  Projection technique for evaluating surgery in Parkinson’s disease , 1969 .